A Perspective on Synthetic Biology in Drug Discovery and Development - Current Impact and Future Opportunities
Review article, 2021
late-stage functionalization
chassis organism
drug discovery
synthetic biology
biofoundry
CRISPR-Cas9
Author
Florian David
Chalmers, Biology and Biological Engineering, Systems and Synthetic Biology
Andrew M. Davis
AstraZeneca AB
Michael Gossing
AstraZeneca AB
Martin A. Hayes
AstraZeneca AB
Elvira Romero
AstraZeneca AB
Louis H. Scott
AstraZeneca AB
Mark J. Wigglesworth
AstraZeneca AB
SLAS Discovery
24725552 (ISSN) 24725560 (eISSN)
Vol. 26 5 581-603Subject Categories
Other Mechanical Engineering
Software Engineering
Bioinformatics and Systems Biology
DOI
10.1177/24725552211000669
PubMed
33834873